Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ARCH

Arch Biopartners (ARCH)

Arch Biopartners Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSXV:ARCH
DateTimeSourceHeadlineSymbolCompany
12/15/202012:08PMPR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ARCHTSXV:ARCHArch Biopartners Inc
12/15/202012:05PMPR Newswire (Canada)IIROC Trading Resumption - ARCHTSXV:ARCHArch Biopartners Inc
12/15/202010:37AMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ARCHTSXV:ARCHArch Biopartners Inc
12/15/202010:35AMPR Newswire (Canada)IIROC Trading Halt - ARCHTSXV:ARCHArch Biopartners Inc
11/05/20207:34AMInvestorsHub NewsWireArch Biopartners Announces Dosing of First Patient in Turkey in Phase II Trial to Treat Complications from Covid-19TSXV:ARCHArch Biopartners Inc
10/16/20209:30AMInvestorsHub NewsWireFirst Patient Dosed in Phase II Trial to Treat Complications in COVID-19TSXV:ARCHArch Biopartners Inc
06/16/202010:05AMPR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ARCHTSXV:ARCHArch Biopartners Inc
06/16/202010:02AMPR Newswire (Canada)IIROC Trading Resumption - ARCHTSXV:ARCHArch Biopartners Inc
06/16/20207:52AMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ARCHTSXV:ARCHArch Biopartners Inc
06/16/20207:50AMPR Newswire (Canada)IIROC Trading Halt - ARCHTSXV:ARCHArch Biopartners Inc
06/08/20207:30AMInvestorsHub NewsWireArch Biopartners submits IND to the FDA for COVID-19 Phase II trial to prevent organ inflammation.TSXV:ARCHArch Biopartners Inc
05/08/20207:03AMInvestorsHub NewsWireArch Biopartners Receives Health Canada Approval for COVID-19 Phase II Human TrialTSXV:ARCHArch Biopartners Inc
04/24/20206:18AMInvestorsHub NewsWireArch Biopartners Applies to Health Canada to Conduct COVID19 Phase II Human Trial to Prevent Lung and Kidney InflammationTSXV:ARCHArch Biopartners Inc
03/17/202010:53AMPR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ARCHTSXV:ARCHArch Biopartners Inc
03/17/202010:49AMPR Newswire (Canada)IIROC Trading Resumption - ARCHTSXV:ARCHArch Biopartners Inc
03/16/20208:45AMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ARCHTSXV:ARCHArch Biopartners Inc
03/16/20208:42AMPR Newswire (Canada)IIROC Trading Halt - ARCHTSXV:ARCHArch Biopartners Inc
09/26/20188:29AMPR Newswire (Canada)Arch Biopartners Announces Completion of GMP Manufacturing of Metablok VialsTSXV:ARCHArch Biopartners Inc
08/14/20188:23AMPR Newswire (Canada)Arch Biopartners Engages Dalton Pharma Services for GMP Manufacturing of MetablokTSXV:ARCHArch Biopartners Inc
 Showing the most relevant articles for your search:TSXV:ARCH